Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases.
Lu
T Y-T
TY
Department of Rheumatology, The Karolinska University Hospital,The Karolinska Institutet, Stockholm, Sweden.
Jónsdóttir
T
T
Jonsdottir
T
T
van Vollenhoven
R F
RF
Isenberg
D A
DA
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000187:drug effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D018655:Lymphocyte Count; D008212:Lymphocyte Depletion; D000069283:Rituximab; D013997:Time Factors
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab